The authors reply

American Journal of Epidemiology

Volumn 167, Issue 9, 2008, Pages 1141-1142

  Kelly, Colleen ^a,c   Arnold, Richard ^a   Galloway, Yvonne ^b   O'Hallahan, Jane ^b  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b MINISTRY OF HEALTH   (New Zealand)

^c Exponent   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

COVARIANCE; CROWDING; DRUG EFFICACY; ETHNIC DIFFERENCE; GROUPS BY AGE; HOUSEHOLD; HUMAN; INFECTION PREVENTION; LETTER; MENINGOCOCCOSIS; NEW ZEALAND; OBSERVATIONAL STUDY; RELIABILITY; SENSITIVITY ANALYSIS; SOCIOECONOMICS; VACCINATION;

EID: 42649091111     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn050     Document Type: Letter

References (2)

1. Lennon D, Stewart J, Crengle S. Re: "A prospective study of the effectiveness of the New Zealand meningococcal B vaccine." (Letter). Am J Epidemiol 2008;167:1140-1.
2. Kelly C, Arnold R, Galloway Y, et al. A prospective study of the effectiveness of the New Zealand meningococcal B vaccine. Am J Epidemiol 2007;166:817-23.